Foehr David 4
4 · Ceribell, Inc. · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Ceribell (CBLL) SVP David Foehr Exercises Options and Sells Shares
What Happened
David Foehr, Senior Vice President, Finance and PAO at Ceribell, exercised stock option rights and sold the resulting shares on Feb 3, 2026. He exercised 3,403 shares (strike $4.70) and 2,153 shares (strike $4.70), paying $15,994 and $10,119 respectively (total strike cost $26,113). He then sold those 3,403 and 2,153 shares in open-market transactions at $20.00 per share, generating gross proceeds of $68,060 and $43,060 (total ~$111,120). The combined transactions appear to be a same-day exercise-and-sell (cashless-style) disposition.
Key Details
- Transaction date: February 3, 2026. Sales executed at $20.00/share; exercises at $4.70/share.
- Shares involved: 3,403 + 2,153 = 5,556 shares sold; gross proceeds ~$111,120; strike costs paid ~$26,113 (net proceeds before taxes/fees ≈ $85,007).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes: Sales were made under a Rule 10b5-1 trading plan adopted Sept 4, 2025 (pre-arranged plan). Option vesting schedule: 25% vested May 31, 2023; remaining vests monthly over 36 months subject to continued service.
- Filing: Report filed Feb 5, 2026 for a Feb 3, 2026 transaction — filed within the typical Form 4 reporting window.
Context
This was an exercise of options followed by immediate open-market sales (a routine way for insiders to monetize vested option gains). The 10b5-1 plan means the sales were pre-scheduled, which is common and does not by itself indicate a change in the insider’s view of the company.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-02-03$4.70/sh+3,403$15,994→ 22,303 total - Sale
Common Stock
[F1]2026-02-03$20.00/sh−3,403$68,060→ 18,900 total - Exercise/Conversion
Common Stock
[F1]2026-02-03$4.70/sh+2,153$10,119→ 21,053 total - Sale
Common Stock
[F1]2026-02-03$20.00/sh−2,153$43,060→ 18,900 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F2]2026-02-03−3,403→ 59,598 totalExercise: $4.70Exp: 2032-06-23→ Common Stock (3,403 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F2]2026-02-03−2,153→ 57,445 totalExercise: $4.70Exp: 2032-06-23→ Common Stock (2,153 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025.
- [F2]Twenty Five Percent (25%) of the shares subject to the option vest on May 31, 2023 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.